SLNOEUR Institutional Ownership
SOLENO THERAPEUTICS INC
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public.
Compare plans.
Cross-institution intelligence
Institutional Research
Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.
Latest filing
May 15, 2026
Public consensus preview
Broad reduction
12/100 institutional research score
4 tracked institutions
Latest filing May 15, 2026
2 reducing across 2 comparable institutions.
Accumulating0
Unchanged0
Reducing2
Exited0
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
52-week range data is not available for this security yet.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
State Street
May 12, 2026 filed
Vanguard Group
Mar 27, 2026 filed
T. Rowe Price Associates
May 15, 2026 filed
Fidelity / FMR
May 7, 2026 filed
Beneficial ownership filing history
Showing 3 of 7 parsed filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| Fidelity / FMR CIK0000315066 | Apr 30, 2026 observed May 7, 2026 filed · 7d Schedule 13G amendment | Reported reduction | 193 -5.6K | 12.00% 0.00 pts | |||
| T. Rowe Price Associates CIK0000080255 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 1.0M -2.4M | 12.00% 0.00 pts | |||
| State Street CIK0000093751 | Mar 31, 2026 observed May 12, 2026 filed · 42d Initial Schedule 13G | Initial Schedule 13G | 2.7M | 12.00% |
Explore more institutional activity
Related research
Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.